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All mature blood cell types in the adult animal arise
from hematopoietic stem and progenitor cells
(HSPCs). However, the developmental cues regu-
lating HSPC ontogeny are incompletely understood.
In particular, the details surrounding a requirement
for Wnt/b-catenin signaling in the development of
mature HSPCs are controversial and difficult to
consolidate. Using zebrafish, we demonstrate that
Wnt signaling is required to direct an amplification
of HSPCs in the aorta. Wnt9a is specifically required
for this process and cannot be replaced by Wnt9b or
Wnt3a. This proliferative event occurs independently
of initial HSPC fate specification, and theWnt9a input
is required prior to aorta formation. HSPC arterial
amplification occurs prior to seeding of secondary
hematopoietic tissues and proceeds, in part, through
the cell cycle regulator myca (c-myc). Our results
support a general paradigm, in which early signaling
events, including Wnt, direct later HSPC develop-
mental processes.
INTRODUCTION
Hematopoietic stem cells (HSCs) both self-renew and generate
all mature blood cell types throughout the lifespan of the verte-
brate organism. Derivation of HSCs in vitro would allow pa-
tient-specific replacement therapies. Currently, deriving an
HSC in vitro that is suitable for therapeutic use is not possible.
Gaining a more thorough understanding of the molecular cues
that direct HSC development in vivo will aid in improving proto-
cols to derive HSCs from pluripotent precursors.
HSCs originate from arterial hemogenic endothelium (HE) dur-
ing vertebrate development, a cell population derived from pos-
terior lateral mesoderm (PLM) in lower vertebrates, which alsoCell Repo
This is an open access article under the CC BY-Nforms the vascular cord and subsequently the aorta (Brown
et al., 2000; Fouquet et al., 1997; Herbert et al., 2009; Jin et al.,
2005; Liao et al., 1997). During the migration of PLM cells, induc-
tive cues from the somites are thought to instruct the fate of HE
from shared vascular precursors (Bertrand et al., 2010a; Burns
et al., 2005; Butko et al., 2015; Clements et al., 2011; Clements
and Traver, 2013; Kobayashi et al., 2014; Leung et al., 2013; Wil-
kinson et al., 2009; Zhen et al., 2013). Hematopoietic stem and
progenitor cells (HSPCs) emerge directly from the floor of the
dorsal aorta (DA; aorta hereafter) in a process termed the endo-
thelial-to-hematopoietic transition (EHT) (Bertrand et al., 2010a;
Kissa and Herbomel, 2010). In zebrafish, EHT begins at 26 hr
post-fertilization (hpf), and the number of emerging HSPCs
peaks at around 36 hpf (Bertrand et al., 2010a; Kissa and Herbo-
mel, 2010). Following this transition, HSPCs enter circulation
through the posterior cardinal vein and migrate to the caudal he-
matopoietic tissue (CHT) in zebrafish (analogous to the placenta/
fetal liver in mammals) for secondary amplification (Murayama
et al., 2006; Tamplin et al., 2015), and finally to the kidney (akin
to the mammalian bone marrow), where they reside for the
remainder of adult life (Jagannathan-Bogdan and Zon, 2013).
Although the anatomical location of these sites varies among
organisms, HSC fate is likely instructed by conserved develop-
mental cues. Understanding the inductive signals that instruct
HSC fate from the mesoderm will be essential to the eventual
derivation of HSCs from pluripotent precursors.
Wnt signaling is vital for the maintenance and development of
stem cell populations in many organ systems, including the in-
testine, skin, and liver (Clevers and Nusse, 2012). Wnt genes
encode lipid-modified, secreted growth factors that initiate
signaling cascades, including the Wnt/b-catenin pathway
(commonly referred to as the ‘‘canonical’’ Wnt pathway). Upon
Wnt binding its cognate receptor encoded by a Frizzled (Fzd)
gene, the b-catenin protein becomes stabilized and enters the
nucleus, where it interacts with the lymphoid enhancer binding
factor/T cell factor (LEF/TCF) transcription factors to drive
expression of Wnt target genes and regulate a variety of devel-
opmental processes.rts 17, 1595–1606, November 1, 2016 ª 2016 The Author(s). 1595
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
The role of Wnt function in HSPC development and function
remains poorly understood, in part because of conflicting re-
ports. For example, loss of Wnt function depleted the HSPC
pool (Fleming et al., 2008; Goessling et al., 2009; Luis et al.,
2009; Zhao et al., 2007), and activation of Wnt signaling resulted
in an increased HSPC number (Baba et al., 2005; Goessling
et al., 2009; Malhotra et al., 2008; Reya et al., 2003; Willert
et al., 2003). In contrast, others have observed a depletion of
the progenitor pool upon b-catenin overexpression (Kirstetter
et al., 2006; Scheller et al., 2006), which may relate to dosage-
dependent effects of Wnt signaling on different populations of
blood cells (Luis et al., 2011). Although these studies establish
thatWnt is essential for the function of adult HSPCs, what is lack-
ing is a clear understanding ofWnt function during the embryonic
development of HSPCs. In particular, it is unclear at what
stage(s) of HSPC development Wnt is critical. Furthermore, the
identification of a specific Wnt ligand regulating HSPC develop-
ment remains elusive. Here, we demonstrate that Wnt signaling
is required prior to formation of the aorta. We further show that
the wnt gene wnt9a is expressed in relevant spatiotemporal do-
mains and that HSPCs are depleted following loss of function of
wnt9a; this loss of function cannot be rescued with ectopic
expression of other wnt genes. This Wnt9a cue drives an early
aortic amplification of HSPCs, which occurs after HSPC emer-
gence begins. This proliferative event is mediated, at least in
part, through regulation of myc-a (also known as c-myc).
RESULTS
Hematopoietic Stem Cell Numbers Are Affected by Wnt
Signaling
Using zebrafish, in which complex developmental processes
can be readily observed and dissected, we examined the
requirement for Wnt signaling during HSPC development. We
observed robust Wnt reporter activity in the floor of the dorsal
aorta at 26 hpf (during HSPC emergence) using double trans-
genic 7X TCF:eGFP (Moro et al., 2012); kdrl:mCherry (Bertrand
et al., 2010a) embryos, which express eGFP from a Wnt respon-
sive sequence and membrane-bound mCherry in the vascula-
ture (Figure S1A), indicating that endothelial cells have received
a Wnt cue.
To monitor the effect of Wnt/b-catenin modulation on HSPCs,
we used LiCl, which activates Wnt/b-catenin signaling through
inhibition of GSK3b, and IWP-L6 (Wang et al., 2013), which in-
hibits Porcn, an essential regulator of Wnt ligand maturation
and secretion (Kadowaki et al., 1996; Komekado et al., 2007).
As previously established, dosages of 0.15 M LiCl or 1.5 mM
IWP-L6 did not alter overall embryonic morphogenesis or vascu-
lature, as visualized by kdrl:mCherry expression (Figure S1B),
but were able to activate or inhibit Wnt signaling, respectively
(van de Water et al., 2001; Wang et al., 2013), as measured by
expression of the Wnt target gene axin2 (Jho et al., 2002)
(Figure S1C).
HSPCs can be identified as kdrl:mCherry; cmyb:eGFP double
positive cells in the floor of the aorta (Bertrand et al., 2010a). To
determine if there was an overall function for Wnt leading to
HSPC emergence, we treated larvae from 10 hpf to 36 hpf
to activate [LiCl] or inhibit [IWP] Wnt and observed emerging1596 Cell Reports 17, 1595–1606, November 1, 2016HSPCs at 36 hpf, when their numbers peak (Bertrand et al.,
2010a; Kissa and Herbomel, 2010). By doing so, we observed
a 2-fold decrease and a 1.5-fold increase in HSPC number after
Wnt inhibition [IWP] or activation [LiCl], respectively (Figures 1A
and 1B). These effects were confirmed with reverse transcription
qPCR for the hematopoietic marker cmyb (Figure S1D), indi-
cating that Wnt signaling regulates HSPC number.
Wnt Is Required Transiently Prior to 20 hpf
To identify the window in HSPC development when Wnt is
required, we used hsp:dntcf transgenic animals, which carry a
dominant-negative version of tcf (dntcf), the expression of which
rapidly inhibits expression of Wnt target genes (Figures S1E and
S1F) (Clevers and Nusse, 2012; Lewis et al., 2004). We per-
formed heat shocks each hour, spanning the window prior to
HSPC emergence (13–26 hpf), followed by analysis of cmyb
expression at 40 hpf by whole-mount in situ hybridization
(WISH) (Kissa et al., 2008). Heat shock before 19 hpf resulted
in a profound loss of cmyb expression in the aorta at 40 hpf,
whereas heat shock at 20 hpf or later had no effect (Figures
1C–1E). Because the dntcf effect on axin2 expression occurs
acutely and is long-lasting (Figure S1F), these results suggested
that the role forWnt in HSPC development occurs prior to 20 hpf.
We confirmed these results with drug treatments (Figure S1G).
Specification, when HSCs acquire identity cues, occurs as
mesodermal cells migrate to the midline underneath the somites
to form the aorta and vein (Kobayashi et al., 2014) (Figure 1I), and
can be monitored with early expression of HSPC markers, such
as runx1. The expression of runx1 at 26 hpf was unaffected
following the drug treatment regime (Figure S1H) (Burns et al.,
2005); dntcf expression at 13 hpf also did not affect runx1 or
cmyb expression at 29 hpf (Figures S1I and S1J). These results
indicate that Wnt signaling positively regulates the number of
emerging HSPCs after specification.
We then sought to establish the timeline for the loss of HSPCs
in the aorta by inducing expression of dntcf at 16.5 hpf and per-
forming WISH for cmyb from 23 to 36 hpf. Using this approach,
we determined that the earliest loss of cmyb+ cells was detected
around 30 to 31 hpf, with an exaggeration of this effect seen
through 33 hpf (Figures 1F–1H). Importantly, we could not detect
an increase in apoptosis in dntcf animals at 32 hpf (Figure S2A).
Therefore, in the absence of Wnt, HSPC numbers were dimin-
ished by a mechanism independent of apoptosis.
Wnt Cue Is Required in Cells of the HE
To test whether the Wnt signal is received by endothelial cells,
we generated upstream activating sequence (UAS):dntcf and
UAS:constitutively active (CA)-b-catenin transgenic animals to
drive the previously reported dntcf or CA-b-catenin transgenes
with Gal4 in the vasculature (Figures S2B–S2E). Similar to the
ubiquitous induction of the hsp:dntcf transgene, endothelial-
specific (using fli1a:Gal4) Wnt inhibition resulted in a loss of
HSPCs at 40 hpf (Figures 2A–2C), whereas CA-b-catenin
expression led to an increase in HSPCs at 40 hpf (Figure S2F),
indicating that the Wnt signal acts upon vascular cells to influ-
ence HSPC development.
To determine if the Wnt cue is required broadly in endothelial
cells, or more specifically in HE, we drove dntcf using a
Figure 1. Wnt Signaling Is Required Transiently Prior to 20 hpf for HSPC Development
(A) kdrl:mCherry; cmyb:eGFP fish were treated with IWP-L6 or LiCl to inhibit and activateWnt signaling, respectively (van deWater et al., 2001; Wang et al., 2013),
from 10 hpf to 36 hpf and imaged at 36 hpf. A, aorta; V, vein. Scale bar, 30 mm.
(B) Quantitation of HSPCs per millimeter of aorta.
(C) Schematic of heat shock regimen.
(D) hsp:dntcf fish were heat shocked every hour from 13 hpf to 24 hpf, fixed at 40 hpf, and analyzed for cmyb expression by WISH. Scale bar, 100 mm.
(E) Quantitation of cmyb+ cells from (D).
(F) Schematic of experimental layout.
(G) hsp:dntcf fish were heat shocked at 16.5 hpf, pools were fixed every hour from 23 to 36 hpf, and they were analyzed for cmyb expression by WISH. Scale
bar, 100 mm.
(H) Quantitation of cmyb+ cells from (G).
(I) HSPCs are specified as endothelial cells ingress toward the midline. Endothelial cells receive specification cues, at least in part, from somatic cells. At 26 hpf,
HSPCs start to emerge from the floor of the dorsal aorta. A, aorta; V, vein.
**p < 0.01; ***p < 0.001; n.s., not significant. Error bars represent SD. See also Figure S1.
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Figure 2. Wnt Cue Is Required in Cells of
the HE
(A) Schematic of transgenic elements used for
endothelial specific expression of dntcf in endo-
thelial cells.
(B) WISH for cmyb at 40 hpf in control and in
fli1a:Gal4; UAS:dntcf fish.
(C) Quantitation of cmyb+ cells from (B).
(D) Schematic of transgenic elements used for
endothelial specific expression of dntcf in the HE.
(E) WISH for cmyb at 40 hpf in control and in
gata2b:Gal4; UAS:dntcf fish.
(F) Quantification of cmyb+ cells from (E).
***p < 0.001. Scale bars, 100 mm. Error bars
represent SD. See also Figure S2.gata2b:Gal4 driver, which is expressed in the earliest known
population of HE (the transient population of endothelial precur-
sors that can differentiate into HSCs) (Butko et al., 2015). Similar
to ubiquitous hsp:dntcf and endothelial-specific transgenes,
Wnt inhibition in gata2b+ cells resulted in a loss of HSPCs at
40 hpf (Figures 2D–2F), indicating that the Wnt signal acts
upon HE to influence HSPC development.
Wnt9a Is Required for HSPC Development
The data presented above establish an essential role for Wnt
signaling in HSPC development. We have previously demon-
strated that the ventral somite signals to neighboring endothelial
precursors during HSPC migration to the embryonic midline
(Clements et al., 2011; Kobayashi et al., 2014). The timing of
the Wnt requirement in HSPC development suggested the so-
mite as a possible source of Wnts. To identify candidate wnt
gene(s), we surveyed expression of 21 wnt genes by qPCR in
myf5-GFP positive (somitic) cells (Chen et al., 2007) prior to
(16.5 hpf) and after (20 hpf). We identified wnt9a as our prime1598 Cell Reports 17, 1595–1606, November 1, 2016candidate because it is expressed at
16.5 hpf, and downregulated at 20 hpf
(Figures S3A–S3C). By WISH, wnt9a tran-
script is detected in the posterior somites
at 16.5 hpf; in regions consistent with
vasculature at 19 hpf; and in the vascula-
ture and the CHT by 28 hpf (Figure 3A).
To determine the effect of loss of wnt9a
on HSPC development, we used a splice-
blocking morpholino (MO) to knock down
wnt9a expression in embryos (Figures
S3D and S3E). Upon injection into em-
bryos, this MO decreased Wnt signaling,
as demonstrated by reduction in axin2
expression (Figure S3F). We observed a
2-fold decrease in kdrl:mCherry; cmyb:
eGFP HSPCs emerging from the floor of
the dorsal aorta at 36 hpf using this MO
and a second MO designed to block
translation of wnt9a (ATG-MO) (Figures
3B–3D). This phenotype was specific to
the hematopoietic system because the
vasculature, aorta, and pronephros wereproperly specified in MO-injected embryos (Figure S3G). MO
knockdown of the closely related wnt9b gene did not affect
HSPCs, suggesting that wnt9a is specifically required for
HSPC development (Figures 3C and 3D). To further determine
whether or not Wnt9a specifically instructs HSPC development,
we performed co-injections of cDNA (to circumvent early
lethality) encoding either wnt9a, wnt9b, or wnt3a with the
wnt9a splice-blockingMO. Ectopic expression ofwnt9a rescued
HSPC numbers in wnt9a morphants (Figures 3C and 3D). In
contrast, ectopic expression of wnt9b or wnt3a did not rescue
the wnt9a MO effect on HSPC numbers (Figures 3C and 3D).
These data suggest that Wnt9a specifically drives HSPC devel-
opment, and that loss of wnt9a cannot be rescued by overex-
pression of other wnt genes.
The loss of HSPCs in wnt9a morphants persisted to later
stages of embryonic hematopoiesis: at 4 days post-fertilization,
we observed a dose-dependent loss of cmyb+ cells in the CHT,
indicating a substantial decline in the total number of HSPCs
(Figure 3E). Similar to enforced expression of dntcf, wnt9a
Figure 3. Wnt9a Is Required for HSPC Formation
(A and B) WISH for wnt9a at 16.5 hpf, 19 hpf, and 24 hpf (A). Scale bars, 0.2 mm; representative images of n = 15. Imaged area is shown in (B).
(C and D) Representative images of kdrl:mCherry; cmyb:eGFP injected as listed (C). HSPCs per millimeter of aorta are quantified in (D). Scale bars, 30 mm.
(E) WISH for cmyb in 4 days post fertilization (dpf) fish treated with 0.1 ng or 1 ng of wnt9a MO. Scale bars, 0.2 mm.
(F) Wnt9a mutants were generated by injection of guide RNA targeting the last portion of the first exon.
(G and H) Expression of cmyb was examined by WISH in 36 hpf WT, wnt9a+/D and wnt9aD/D- zebrafish (G) and quantified in (H).
Scale bars, 100 mm. *p < 0.05; ***p < 0.001; n.s., not significant. Error bars represent SD. See also Figure S3.
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Figure 4. HSPCs Expand in the Aorta
(A) The heart tubes of gata2b:GFP fish were injected with 1 nL of 10 mM EdU
at 26 hpf, and fixed and stained for cells that had divided as well as GFP at
33 hpf (n = 10).
(B) Representative confocal image of gata2b+ cells that have undergone cell
division in the aorta (arrowheads).
(C–E). gata2b:GFP;kdrl:mCherry fish were treated with 10 mM 50 fluorouracil
(5FU) from 24 to 35 hpf (C), confocal imaged at 36 hpf (D), and gata2b+ cells
quantified (E).
(F and G) G1 arrested (mCherry+) endothelial cells (GFP+) from wnt9a mor-
phant and control fish (n = 100 embryos per condition) were collected by FACS
at 28 hpf (F) and compared by qPCR for gata2b (G).
Scale bars, 30 mm. Error bars represent SD. See also Figure S4.knockdown had no effect on runx1 expression at 26 hpf (Figures
S3H and S3I). Finally, because recent reports have indicated that
MOs may have non-specific effects (Kok et al., 2015; Schulte-
Merker and Stainier, 2014; van Impel et al., 2014), we confirmed
that genetic mutation of wnt9a results in loss of cmyb+ cells at
36 hpf as well (Figures 3F–3H). We confirmed that somitic
wnt9a is required for HSPC emergence by injecting aUAS:wnt9a1600 Cell Reports 17, 1595–1606, November 1, 2016cDNA construct into fish with a somitic gal4 driver (phldb1:gal4),
in the context of the wnt9a MO, and found that somitic overex-
pression of wnt9a was sufficient to partially rescue the loss of
HSPCs (Figures S3J and S3K). Taken together, these results
indicate a defect in the emergence of HSPCs following loss of
wnt9a.
Hematopoietic Precursors Expand in the Aorta
Next, we aimed to determine the mechanism underlying HSPC
reduction upon loss ofWnt function. HSCs arise from hemogenic
cells in the aorta, enter circulation, and seed the CHT, where they
proliferate and differentiate before migrating to the adult he-
matopoietic tissues (Murayama et al., 2006). The observation
that diminished Wnt signaling led to a decrease in aortic HSPCs
suggested that HSPCs also undergo an expansion in the aorta.
HSPCs can also be detected using kdrl:mCherry; gata2b:GFP
double transgenic animals (Butko et al., 2015). We used this
line for EdU pulse labeling at 26 hpf to detect proliferation events
in emerging HSPCs at 33 hpf. With this approach, we could
detect gata2b+ cells that had proliferated, prior to exit from the
aorta (Figures 4A and 4B). We also detected proliferation events
in kdrl:mCherry; cmyb:GFP animals at 32 hpf and as early as 30
hpf (Figures S4A and S4B). To determine the extent to which
HSPCs proliferate in the aorta, we treated kdrl:mCherry;
gata2b:GFP animals from 26 to 35 hpf with 5-fluorouracil, which
selectively kills cells that have undergone DNA synthesis (Heidel-
berger et al., 1957). This resulted in a 2.5-fold reduction in the
average number of HSPCs at 36 hpf (Figures 4C–4E), confirming
a requirement for amplification of nascent HSPCs in the aorta.
Wnt9a Drives HSPC Proliferation in the Aorta
throughmyca
The loss of HSPCs independent of apoptosis and the concomi-
tant requirement for proliferation in the aorta suggested that in
the absence of a Wnt cue, HSPCs may be G1 arrested; the
FUCCI fish identifies G1-phase cells with the red fluorescent pro-
tein mCherry (Bouldin and Kimelman, 2014; Sugiyama et al.,
2009). Endothelial cells in the G1 phase can therefore be sorted
from kdrl:GFP; FUCCImorphant fish and compared to the same
population from uninjected controls. We sorted G1-phase endo-
thelial cells (kdrl:GFP; FUCCI) from morphant and uninjected
fish. At 28 hpf, G1 cells from wnt9aMO-injected fish had robust
expression of gata2b, whereas we were unable to detect gata2b
transcripts in the uninjected sample; gata2b expression in un-
sorted fish was similar in morphant and control fish, suggesting
that HSPCs are G1 arrested in the absence of wnt9a (Figures 4F
and 4G). We could also detect an increase in G1-arrested
endothelial cells in wnt9a MO-injected animals (Figures S4C
and S4D).
Entrance to the replicative S phase of the cell cycle is gov-
erned by a series of cellular events requiring D-class cyclins
and their cofactors, cdk2 and cdk4 (Bertoli et al., 2013), which
we predicted to be decreased in Wnt-reduced animals. Consis-
tent with this model, we observed a profound loss of cyclinD2b
and cdk4, and a small, but significant, decrease in cyclinD1
and cdk2 in Wnt-suppressed (dntcf+) endothelial cells at 30 hpf
(Figures 5A and B). The transcriptional regulator and context-
specific Wnt target gene myca, which acts upstream of these
Figure 5. Wnt9aAffectsEndothelialgata2b+
G1-S Cell Cycle Progression throughmyca
(A) Endothelial cells (mCherry+) were collected by
FACS from hs:dntcf:IRES-GFP; kdrl:mCherry fish
at 30 hpf after heat shock at 16 hpf (n = 100 em-
bryos per condition).
(B) Wnt inhibited (dntcf;GFP+) cells were com-
pared to control (GFP) cells by qPCR after being
sorted by FACS.
(C and D) AB* fish were injected with wnt9a MO,
myca mRNA, or both; phldb4:Gal4 fish were in-
jected with wnt9a MO, UAS;myca plasmid, and
transposase mRNA, fixed at 40 hpf, analyzed by
WISH for cmyb (C), and quantified in (D).
Scale bar, 100 mm. *p < 0.05; ***p < 0.001; n.s.,
not significant. Error bars represent SD. See also
Figure S5.cell cycle regulators (Mateyak et al., 1999), was also downregu-
lated in dntcf+ endothelial cells (Figure 5B), whereas normal
myca levels increase in endothelial cells during development,
concordant with endothelial expansion (Figure S5A). We could
not detect a loss of these cell cycle regulators at earlier time
points, such as 24 hpf (Figure S5B). Accordingly, introducing
myca mRNA in wnt9a morphants was sufficient to rescue the
loss of cmyb+ cells at 40 hpf (Figures 5C and 5D) and of cell cycle
regulators by 28 hpf (Figure S5C), indicating that at least a
portion of Wnt9a function in HSPCs proceeds through myca.
Finally, expressingmyca expression under control of the gata2b
promoter (in gata2b:KalTA4; UAS:myca) was sufficient to rescue
the loss of wnt9a in morphants (Figures 5C and 5D), further sup-
porting this requirement in the HE. Taken altogether, our results
indicate that Wnt9a drives an early amplification of HSPCs up-
stream of the cell cycle regulator myca in the HE (Figure 6).
DISCUSSION
Wnt signaling regulatesmultiple stages of hematopoiesis, but re-
quirements for the specific molecules that mediate these signals
are not well understood. This study sought to understand the
regulation of specificwnt genes that instruct early hematopoietic
development. We found that a single wnt gene,wnt9a, mediates
a critical Wnt signal that is received by the endothelium prior to
20 hpf for HSPC emergence in the zebrafish. The Wnt9a signalCell Reporstimulates a previously unrecognized
HSPC amplification event in the aorta
that is mediated through activation of
myca, a Wnt-regulated gene, and impor-
tant regulator of cell proliferation.
Previous work has demonstrated an
early Wnt signaling requirement for the
production of long-term HSCs in mouse
and zebrafish (Goessling et al., 2009;
Ruiz-Herguido et al., 2012); however,
the identity of Wnt signaling components,
particularly which of the numerous Wnts,
has remained unclear. Here, we demon-
strate a unique requirement for the so-matically expressed wnt9a in HSPC development. Knockdown
of wnt9a causes a decrease in cmyb+ hematopoietic precursors
at 36 hpf, consistent with previous global knockdown of Wnt
function in mouse and zebrafish (Goessling et al., 2009; Luis
et al., 2009, 2011; Ruiz-Herguido et al., 2012). Extending these
studies, we have found that loss of wnt9a expression does not
cause a defect in HSPC specification, as evidenced by normal
runx1 expression in the aorta at 26 hpf. This is also in contrast
to other factors known to affect HSPC development at the level
of specification (Butko et al., 2015; Clements et al., 2011; Espı´n-
Palazo´n et al., 2014; Kim et al., 2014; Kobayashi et al., 2014; Lee
et al., 2014; Pouget et al., 2014). For example, Wnt16 acts
through a non-canonical Wnt pathway upstream of Notch
signaling to specify HSPC identity (Clements et al., 2011), a
process that is mediated by an interaction between the ventral
somite and migrating vascular precursors (Kobayashi et al.,
2014).
Loss of wnt9a cannot be compensated for by overexpression
of otherWnt genes, suggesting that the requirement for Wnt9a in
HSPC development is specific. This specificity is surprising
because in many experimental settings, individual Wnt proteins
produce similar effects and are often interchangeable. Our
current understanding of specific Wnt interactions with their
cognate receptors is quite limited and largely restricted to
in vitro studies. For example, wingless (the Drosophila Wnt1 or-
tholog) interacts with the cysteine-rich domains (CRDs) of bothts 17, 1595–1606, November 1, 2016 1601
Figure 6. EarlyWnt9a Cue Is Required for Later Hematopoietic Stem
Cell Amplification
Prior to 20 hpf, ingressing cells of the posterior lateral mesoderm travel
beneath the somites. Inductive cues direct from the somite instruct the fate of
these cells, some of which are destined to become HE, and later, HSPCs.
Wnt9a is expressed in the somite at this stage. By 26 hpf, the aorta has formed
and HSPCs have begun to emerge. In the absence of Wnt9a, this early
emergence is unaffected, indicating the HSPC fate specification has occurred
properly. By 31 hpf, normal HSPCs undergo an expansion event, whereas
those in Wnt9a-deficient animals do not.Fz and Dfz2 (two Drosophila Fzd proteins that act redundantly in
establishing segment polarity in the embryo), but with 10-fold
lower affinity for Fz than for Dfz2 (Rulifson et al., 2000). Deter-
mining specificities of Wnts for their receptors is confounded
by the large number of Wnts and Wnt receptors involved: the
mammalian genome contains 19 wnt and 10 Fzd genes and
the zebrafish genome contains 20+ wnt and 14 fzd genes.
A recent study analyzed the interactions of four Wnt proteins
with six Fzd CRDs and found a significant range in binding affin-
ities among individual pairs (Dijksterhuis et al., 2015). Identifying
the Fzd(s) and co-receptors expressed in the pre-HE during
HSPC development will be informative in studying the interaction
of Wnt9a with these potential receptors.
Wnt9a is well conserved among vertebrates (Curtin et al.,
2011; Kamel et al., 2013) and is expressed in mouse HSPCs
(Wu et al., 2012), indicating possible conservation of function
during hematopoietic development. In this context, it is worth
noting that in both zebrafish and mammals, the wnt9a gene is
syntenic to wnt3a (Nusse, 2001), suggesting coordinate regula-
tion of these two wnt genes. Importantly, Wnt3a has been impli-
cated in HSC self-renewal in the mouse (Luis et al., 2009; Willert
et al., 2003), but does not appear to have a role in zebrafish he-
matopoiesis (Buckles et al., 2004; Clements et al., 2009; Thorpe
et al., 2005). A role forWnt9a inmammalian hematopoietic devel-
opment has not yet been addressed.
Interestingly, zebrafish embryos that are deficient for Wnt
signaling do not show a hematopoietic phenotype until 30 hpf,1602 Cell Reports 17, 1595–1606, November 1, 2016which is 10 hr removed from the time that the signal is required.
This delayed effect of aWnt signal may be related to the concept
of cellular memory put forth by Vincent and colleagues, who pro-
posed that earlier signaling events allow persistent expression of
relevant target genes (Alexandre et al., 2014). Our data indicate
that during this time, cells of the HE are primed for amplification
in the dorsal aorta. Upon loss ofWnt signaling via global pathway
inhibition or wnt9a knockdown, these emerging HSPCs are ar-
rested in the G1 phase of the cell cycle, causing a decrease in
proliferating HSPCs and overall HSPC numbers. This regulation
of the cell cycle is mediated, at least in part, bymyca (the zebra-
fish homolog of mammalian C-MYC), which, among other tar-
gets, controls transcription of D-class cyclin genes and their
associated cyclin-dependent kinases (Amati et al., 1998; Hanson
et al., 1994; Mateyak et al., 1999). These genes are downregu-
lated when Wnt is inhibited, and loss of HSPCs in this context
can be rescued with myca. Our findings are consistent with re-
ports showing that MYC expression is vital to maintaining
HSPC numbers and function (Delgado and Leo´n, 2010; Laurenti
et al., 2008) and studies using MYC as a factor to facilitate re-
programming to HSPC fate (Riddell et al., 2014), and also that
MYC is a context-dependentWnt target (Cole et al., 2010; Kolligs
et al., 1999;Muncan et al., 2006; Sansomet al., 2007). Although it
appears that Myca operates downstream of the Wnt9a cue,
further investigation will be required to determine the nature of
the timing delay between 20 and 31 hpf because bothmyca tran-
script and protein are known to be tightly controlled, with esti-
mated half-lives of 20–30 min or less (McCormack et al., 1984;
Rabbitts et al., 1985). Interestingly, Myca and Notch1 (which is
critical to HSC fate specification) have been previously shown
to interact (Bertrand et al., 2010b; Bigas et al., 2013; Burns
et al., 2005; Kim et al., 2014; Kumano et al., 2003; Palomero
et al., 2006). However, we could not detect any differences in
Notch reporter expression inwnt9amorphants (data not shown),
suggesting that this process occurs independently of Notch
signaling. This suggests that tight regulation of cell proliferation
by the Wnt signaling pathway through myca is critical for proper
hematopoietic development.
Our findings show a unique role for Wnt9a in zebrafish HSPC
development. This signal is received by cells of the HE as they
ingress to the midline to form the vascular cord prior to 20 hpf.
The Wnt9a signal instructs HSPC emergence, but not HSPC
specification, via priming HSPCs for later aortic amplification.
The specific Wnts necessary to differentiate human pluripotent
stem cells to hematopoietic or other lineages are often unknown
or unused in protocols. Instead, global small molecule pathway
activators or inhibitors are often favored because of their wide-
spread availability and inexpensive nature. Our data indicate
that the specific molecules that mediate a specific signal during
in vivo development may provide more precise developmental
instruction than small molecules with non-specific effects on
signaling pathways, especially because differences in Wnt re-
quirements could also be reflective of precise timing and ligand
requirements. Understanding the precise identity of these
instructive signals and their temporal regulation is critical for
improving differentiation protocols to develop HSCs in vitro,
which one day could be used as a therapeutic alternative to
bone-marrow transplants.
EXPERIMENTAL PROCEDURES
Zebrafish Lines and Maintenance
Zebrafish were maintained and propagated according to University of Califor-
nia and local institutional animal care and use committee policies (protocol
S04168). AB*, Tg(cmyb:eGFP)zf169Tg, Tg(hsp:Gal4)kca4Tg/+, Tg(kdrl:Cherry-
CAAX)y171, Tg(fli1a:eGFP), Tg(kdrl:eGFP)s843, Tg(7X TCF-X.laveis-siamois:
eGFP)ia4, Tg(fli1a:Gal4), Tg(gata2b:KalTA4; UAS:Lifeact:eGFP), Tg(Dual
FUCCI), Tg(fli1a:EcRF-VP16), Tg(phldb1:KalTA4), and Tg(hsp70l:dntcf7l1a)w26
lines have been previously described (Bertrand et al., 2008, 2010a; Bouldin
and Kimelman, 2014; Butko et al., 2015; Espı´n-Palazo´n et al., 2014;
Jin et al., 2005; Kobayashi et al., 2014; Lawson and Weinstein, 2002; Lewis
et al., 2004; Moro et al., 2012; North et al., 2007; Sugiyama et al., 2009; Swift
et al., 2014). Tg(UAS-dntcf7l1a-CG2), Tg(UAS: wnt9a) and Tg(UAS:myca)
founders were established by injecting 25 pg of the constructs described
below with 100 pg of transposase mRNA at the one-cell stage. For simplicity
in the text, these lines are referred to with shortforms listed in square brackets:
Tg(cmyb:eGFP)zf169Tg [cmyb:eGFP], Tg(kdrl:Cherry-CAAX)y171 [kdrl:mCherry],
Tg(fli1a:eGFP) [fli1a:eGFP], Tg(kdrl:eGFP)s843 [kdrl:eGFP], Tg(7X TCF-X.laveis-
siamois:eGFP)ia4 [7XTCF:eGFP], Tg(gata2b:KalTA4; UAS:Lifeact:eGFP)
[gata2b:eGFP] and Tg(hsp70l:dntcf7l1a)w26 [hsp:dntcf], Tg(UAS-dntcf7l1a-
CG2)[UAS:dntcf], Tg(UAS: wnt9a) [UAS: wnt9a], Tg(UAS:myca) [UAS:myca],
Tg(phldb1:KalTA4) [phldb:KalTA4], and Tg(Dual FUCCI) [FUCCI]. MOs for
wnt9a were targeted to retain the first intron (Figure S3D) with sequence
50-GAAAGAATTGTCCTGCCTACCCGAA-30, or targeted to block the ATG start
codon (wnt9a ATG-MO) with sequence 50-CCAGGAGAAGGTGTCCATCCAG
CAT-30 from GeneTools. One-cell stage zygotes were injected with 1 ng of
wnt9a MO, and retention of the intron was confirmed by PCR. The ATG-MO
was used at a concentration of 2 ng per injection. Mutation of the wnt9a locus
was achieved by injecting 100 ng of cas9 mRNA (Trilink) and 100 ng of short
guide RNA (sgRNA) targeting exon 1 (ATTGGGACGGCTAATAGATT). Muta-
tions were confirmed by sequencing individuals. Modulation of Wnt signaling
was carried out using 0.15 M LiCl or 1.5 mM IWP-L6 in E3 with PTU as previ-
ously described (van de Water et al., 2001; Wang et al., 2013). For heat shock
experiments, fishwere heat shocked at 38C for 10 or 30min andwere allowed
to return to 28.5C gradually. 5-Fluorouracil treatments were performed at
10 mM, with DMSO as a vehicle. Rescue experiments were performed using
10-pg myca mRNA synthesized using the SP6 mMessage machine kit
(Ambion), according to the manufacturer’s recommendations.
WISH
RNA probe synthesis was carried out according to the manufacturer’s recom-
mendations using the DIG-RNA labeling kit (Roche). Probes for dll4, hey2,
notch1b,msr, kdrl, cdh17, cmyb, and runx1andWISHprotocols havebeenpre-
viously described (Clements et al., 2011; Kobayashi et al., 2014; Rowlinson and
Gering,2010),whereas theprobeconstruct forwnt9awasagift fromW.Herzog.
Fluorescence-Activated Cell Sorting and qPCR
Zebrafish were dissociated using Liberase TM (Roche) and filtered through an
80-mm filter. Cells were sorted on a BD Influx cell sorter according to standard
procedures. RNA and cDNA were synthesized by standard means and qPCR
was performed using FastStart Universal SYBR Green Master Mix (Roche)
according to the manufacturer’s recommendations and analyzed using the
2-DDCt method (Schefe et al., 2006). Sequences of primers are shown in the
Supplemental Experimental Procedures.
EdU and TUNEL Labeling
Zebrafish larvae were injected with 1 nL of 10 mM EdU into the heart at 26 hpf,
fixed at later time points, and stained using the Click-iT EdU imaging kit
(Invitrogen) according to the manufacturer’s recommendations. Transgenic
reporters were stained using standard immunofluorescence with chicken
anti-GFP (Aves Labs) and anti-mCherry [1C51] (abcam). TUNEL staining was
carried out as previously described (Espı´n-Palazo´n et al., 2014).
Quantifying HSPCs
HSPCs were quantified by counting the number of kdrl:mCherry; cmyb:eGFP
or kdrl:mCherry; gata2b:GFP double positive cells in the floor of the DA in theregion above the yolk extension in a 625-mm confocal Z stack encompassing
the entire mediolateral segment of the aorta. The number of HSPCs per milli-
meter was calculated from these data. Confocal images were generated by
stacking one to four individual Z slices. When quantifying WISH data, the num-
ber of cmyb+ cells was counted above the yolk extension.
Plasmid Construction
Zebrafish dntcf7l1a lacking the b-catenin-binding domain was amplified by
PCR and subcloned to pENTR1a dual selection and recombined with p5E-
UAS, p3E-pA, and the Tol2 cmlc2:eGFP destination vector from the Tol2 kit
(Kwan et al., 2007). Constructs to express zebrafish myca, wnt3a, wnt9a,
and wnt9b were established by subcloning cDNA encoding each gene into
pCS2+.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.10.027.
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